While headlines about 'Ozempic face' warn that the rapid weight loss associated with GLP-1 drugs can prematurely age people's ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Four patients in Denmark, who experienced vision loss after using Novo Nordisk’s popular weight-loss and diabetes drugs ...

MILLIONS of us are on them, and the rest of us are fat jab-curious, intrigued by the ‘miracle’ shots melting waistlines ...

Four Danish patients who experienced vision loss after using Novo Nordisk's Wegovy and Ozempic were awarded compensation ...

A Novo Nordisk challenge has driven Regen Doctors to voluntarily discontinue compounded semaglutide product claims, adding to the Danish drugmaker’s string of wins against companies selling versions ...

An estimated 12 percent of U.S. adults are currently taking a GLP-1 drug, such as Ozempic or Wegovy, a KFF survey last week ...

HealthDay News — People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications. The company announced that ...

Novo Nordisk is quietly coming out of the storm despite the prevailing pessimism, especially among retail investors. Click ...

The once-a-day pill belongs to class of medications called GLP-1 agonists, like Mounjaro, which suppress appetite and make ...

Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects. Brain scientists are looking for ways ...